南美超级胎牛血清999尝鲜特惠
转染试剂低至5折
基质胶阶梯特惠
积分商城,好礼送不停
南美超级胎牛血清999尝鲜特惠
转染试剂低至5折
基质胶阶梯特惠
积分商城,好礼送不停

白介素-8(IL-8)、转化生长因子β(TGF-β)及整合素αvβ3(ITGB1)形成的信号轴,在口腔鳞状细胞癌(OSCC)侵袭前沿区域精确调控成纤维细胞的时空重编程过程,进而构建双重免疫抑制微环境并促进肿瘤对免疫治疗产生耐药性。

The PLAU-ITGB1-TGF-β axis orchestrates spatiotemporal reprogramming of fibroblasts at the invasive front to drive dual immunosuppressive niche and immunotherapy resistance in oral squamous cell carcinoma

Xiong Yili, Liu Shaopeng, Zhao Lianyu, Liu Xinze, Zhang Hanzhi, Wang Haoran, Zhang Dongsheng, Wang Changlong, Wu Haiwei

Journal:Cell Death & Disease

IF:12.2

DOI:10.1038/s41419-026-09110-4

PMID:42463632

Published:2026-07-16

research field:肿瘤学基因组编辑分子生物学细胞衰老癌症免疫治疗

Abstract

The initiation and progression of cancer are driven by the dynamic interplay between somatic mutations and the tumor microenvironment. Identifying core cell populations driving malignant transformation and understanding the intercellular interactions within the tumor microenvironment are, therefore, crucial for early diagnosis and effective treatment. Here, we construct a spatiotemporal atlas of oral squamous cell carcinoma (OSCC) progression by integrating multi-omics approaches. Our analysis reveals that the critical driver gene PLAU activates the TGF-β pathway via ITGB1, thereby promoting the conversion of fibroblasts into the COL11A1⁺ fibroblast (COL11A1⁺ Fib). These specialized fibroblasts remodel the extracellular matrix (ECM), collectively establishing an immunosuppressive niche composed of malignant epithelial cells, COL11A1 + Fib, and regulatory T cells (Tregs). Importantly, targeting COL11A1 + Fib alleviates this immunosuppressive niche and curbs OSCC progression. Our findings underscore the potential of COL11A1 + Fib as a predictive biomarker, especially in combination with immunotherapy. Collectively, this work demonstrates that the PLAU-ITGB1-TGF-β axis drives the formation of an Epi-COL11A1 + Fib-Treg immunosuppressive niche that fuels OSCC malignancy.

本文使用的Yeasen产品

购物车
客服
转染试用